Related Experiment Video
Updated: Dec 15, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Twist-mediated PAR1 induction is required for breast cancer progression and metastasis by inhibiting Hippo pathway
Yifan Wang1,2,3, Ruocen Liao1,3, Xingyu Chen1,3
1Department of Pathology and Pathophysiology, and Department of Surgical Oncology (breast center) of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract:
Breast cancer is considered to be the most prevalent cancer in women worldwide, and metastasis is the primary cause of death. Protease-activated receptor 1 (PAR1) is a GPCR family member involved in the invasive and metastatic processes of cancer cells. However, the functions and underlying mechanisms of PAR1 in breast cancer remain unclear. In this study, we found that PAR1 is highly expressed in high invasive breast cancer cells, and predicts poor prognosis in ER-negative and high-grade breast cancer patients. Mechanistically, Twist transcriptionally induces PAR1 expression, leading to inhibition of Hippo pathway and activation of YAP/TAZ; Inhibition of PAR1 suppresses YAP/TAZ-induced epithelial-mesenchymal transition (EMT), invasion, migration, cancer stem cell (CSC)-like properties, tumor growth and metastasis of breast cancer cells in vitro and in vivo. These findings suggest that PAR1 acts as a direct transcriptionally target of Twist, can promote EMT, tumorigenicity and metastasis by controlling the Hippo pathway; this may lead to a potential therapeutic target for treating invasive breast cancer.
Insights
Protease-activated receptor 1 (PAR1) drives breast cancer invasion and metastasis by activating YAP/TAZ signaling. Inhibiting PAR1 may offer a new therapeutic strategy for invasive breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Breast cancer is the most common cancer globally, with metastasis being the leading cause of mortality.
- Protease-activated receptor 1 (PAR1), a G protein-coupled receptor, is implicated in cancer cell invasion and metastasis, but its specific role in breast cancer is not fully understood.
Purpose of the Study:
- To investigate the role and mechanism of PAR1 in breast cancer progression, focusing on its relationship with the Hippo pathway and epithelial-mesenchymal transition (EMT).
Main Methods:
- Analysis of PAR1 expression in breast cancer cells and patient data.
- Investigating the transcriptional regulation of PAR1 by Twist.
- Examining the effects of PAR1 inhibition on Hippo pathway signaling (YAP/TAZ), EMT, cancer stem cell properties, and metastasis in vitro and in vivo.
Main Results:
- PAR1 is highly expressed in invasive breast cancer cells and correlates with poor prognosis in specific patient subgroups (ER-negative, high-grade).
- Twist directly induces PAR1 expression, which in turn inhibits the Hippo pathway, leading to YAP/TAZ activation.
- Inhibition of PAR1 suppressed YAP/TAZ-driven EMT, invasion, migration, cancer stem cell characteristics, tumor growth, and metastasis.
Conclusions:
- PAR1 is a direct transcriptional target of Twist and promotes breast cancer invasion, tumorigenicity, and metastasis by modulating the Hippo pathway.
- PAR1 represents a potential therapeutic target for treating invasive breast cancer.
More Related Videos
11:13Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways